Cambridge Investment Research Advisors
EXEL icon

Cambridge Investment Research Advisors’s Exelixis EXEL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.85M Buy
159,749
+74,167
+87% +$3.19M 0.02% 789
2025
Q4 		$3.75M Sell
85,582
-109,544
-56% -$4.53M 0.01% 1084
2025
Q3 		$8.06M Buy
195,126
+108,984
+127% +$4.38M 0.02% 671
2025
Q2 		$3.8M Buy
86,142
+2,050
+2% +$81.9K 0.01% 1003
2025
Q1 		$3.1M Buy
84,092
+15,183
+22% +$541K 0.01% 1068
2024
Q4 		$2.29M Sell
68,909
-81,321
-54% -$2.64M 0.01% 1266
2024
Q3 		$3.9M Sell
150,230
-7,675
-5% -$191K 0.01% 945
2024
Q2 		$3.55M Buy
157,905
+2,732
+2% +$60.6K 0.01% 944
2024
Q1 		$3.68M Sell
155,173
-10,732
-6% -$239K 0.01% 922
2023
Q4 		$3.98M Buy
165,905
+152,370
+1,126% +$3.31M 0.02% 818
2023
Q3 		$296K Sell
13,535
-430
-3% -$8.99K ﹤0.01% 2503
2023
Q2 		$267K Sell
13,965
-26,643
-66% -$514K ﹤0.01% 2638
2023
Q1 		$788K Buy
40,608
+24,302
+149% +$423K ﹤0.01% 1740
2022
Q4 		$262K Sell
16,306
-89,633
-85% -$1.46M ﹤0.01% 2533
2022
Q3 		$1.66M Buy
105,939
+86,608
+448% +$1.67M 0.01% 1146
2022
Q2 		$402K Sell
19,331
-7,383
-28% -$152K ﹤0.01% 2131
2022
Q1 		$606K Sell
26,714
-1,559
-6% -$30.4K ﹤0.01% 1944
2021
Q4 		$517K Buy
28,273
+42
+0.1% +$804 ﹤0.01% 2082
2021
Q3 		$597K Sell
28,231
-6,895
-20% -$128K ﹤0.01% 1911
2021
Q2 		$640K Sell
35,126
-77,588
-69% -$1.81M ﹤0.01% 1866
2021
Q1 		$2.55M Buy
112,714
+27,591
+32% +$623K 0.01% 891
2020
Q4 		$1.71M Buy
85,123
+15,252
+22% +$319K 0.01% 1010
2020
Q3 		$1.71M Buy
69,871
+5,914
+9% +$138K 0.01% 889
2020
Q2 		$1.52M Sell
63,957
-737
-1% -$17.1K 0.01% 897
2020
Q1 		$1.11M Buy
64,694
+8,923
+16% +$163K 0.01% 919
2019
Q4 		$983K Buy
55,771
+6,545
+13% +$111K 0.01% 1155
2019
Q3 		$871K Buy
49,226
+3,440
+8% +$69.6K 0.01% 1142
2019
Q2 		$978K Buy
45,786
+22,245
+94% +$466K 0.01% 1036
2019
Q1 		$560K Buy
23,541
+3,431
+17% +$78.2K 0.01% 1409
2018
Q4 		$396K Sell
20,110
-3,386
-14% -$60.4K ﹤0.01% 1453
2018
Q3 		$416K Buy
23,496
+3,428
+17% +$66.8K ﹤0.01% 1558
2018
Q2 		$432K Buy
20,068
+1,903
+10% +$39.4K ﹤0.01% 1479
2018
Q1 		$402K Buy
18,165
+3,496
+24% +$96.6K ﹤0.01% 1465
2017
Q4 		$446K Sell
14,669
-2,406
-14% -$64K 0.01% 1380
2017
Q3 		$414K Buy
17,075
+3,502
+26% +$93.2K 0.01% 1350
2017
Q2 		$334K Buy
+13,573
New +$287K ﹤0.01% 1449
2017
Q1 		– Sell
-11,270
Closed -$168K – 1779
2016
Q4 		$168K Sell
11,270
-5,300
-32% -$76.5K ﹤0.01% 1533
2016
Q3 		$212K Buy
+16,570
New +$179K ﹤0.01% 1516

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Cambridge Investment Research Advisors's EXEL Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Exelixis (EXEL) stake by 87% in Q1 2026, buying an estimated $3.19M and bringing the position to 159,749 shares worth $6.85M. The position accounts for 0.02% of the portfolio, ranked #789.

Cambridge Investment Research Advisors first reported a position in EXEL in Q3 2016 and has held it in 38 quarters since. The position peaked at $8.06M in Q3 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Cambridge Investment Research Advisors held 159,749 shares of Exelixis worth $6.85M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 74,167 Exelixis shares in Q1 2026, an estimated $3.19M.
  • Exelixis made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #789 holding.
  • Cambridge Investment Research Advisors first reported a position in Exelixis in Q3 2016 and has held it in 38 quarters since.
  • Cambridge Investment Research Advisors's Exelixis position peaked at $8.06M in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.